Turing Pharmaceuticals Retreats From Plan To Raise Price Of Daraprim

NPR’s All Things Considered discusses the controversy over a planned increase in the cost of an AIDS drug from less than $14 to $750, which Turing Pharmaceuticals has said it will now reduce.

 

+ posts

Share

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Subscribe to get the latest consumer news

More consumer News